BRIEF published on 08/05/2024 at 15:38, 3 months 19 days ago The Vanguard Group, Inc.: Britvic plc Position Disclosure Disclosure Takeover Code Vanguard Positions Britvic
PRESS RELEASE published on 08/05/2024 at 15:33, 3 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.45% stake in Britvic plc with 13,568,674 ordinary securities. Dealings include purchases and sales of 20p ordinary shares Britvic Plc The Vanguard Group Stake Disclosure Dealings Ordinary Securities
BRIEF published on 08/02/2024 at 15:27, 3 months 22 days ago Vanguard Group Discloses Position in Britvic plc Ordinary Shares Takeover Code Vanguard Group Stake Disclosure Britvic
PRESS RELEASE published on 08/02/2024 at 15:22, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.45% stake in Britvic plc through an open position disclosure on 01 Aug 2024. Details of securities dealt are included Securities Britvic Plc The Vanguard Group Stake Disclosure Open Position
BRIEF published on 08/01/2024 at 16:54, 3 months 23 days ago BlackRock Increases Stake in Britvic to 5.36% Voting Rights Shareholding BlackRock Financial Instruments Britvic
PRESS RELEASE published on 08/01/2024 at 16:49, 3 months 23 days ago Holding(s) in Company BlackRock, Inc. crosses threshold; acquires 5.36% voting rights in Britvic plc (BVIC). TR-1 notification of major holdings BlackRock, Britvic Plc, BVIC, TR-1 Notification, Major Holdings
BRIEF published on 08/01/2024 at 15:21, 3 months 23 days ago The Vanguard Group, Inc. Discloses Significant Position in Britvic plc Form 8.3 Takeover Code Securities Disclosure Vanguard Britvic
PRESS RELEASE published on 08/01/2024 at 15:16, 3 months 23 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.44% stake in Britvic plc as of 31 July 2024. Details of securities owned and recent dealings provided Securities Dealings Britvic Plc The Vanguard Group Financial Disclosure Stake Disclosure
BRIEF published on 07/31/2024 at 15:53, 3 months 24 days ago The Vanguard Group, Inc.: Britvic plc Shares Disclosure Securities Shares Disclosure Vanguard Britvic
PRESS RELEASE published on 07/31/2024 at 15:48, 3 months 24 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.42% ownership in Britvic plc as of 30 July 2024. Details on securities held and recent transactions provided Securities Transactions Britvic Plc Vanguard Group Ownership Disclosure
Published on 11/22/2024 at 23:55, 2 days 1 hour ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 1 hour ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 2 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 2 days 2 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/24/2024 at 19:16, 6 hours 9 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 6 hours 18 minutes ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 7 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 7 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 18 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 6 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 7 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 7 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
